Displaying 1121 - 1140 of 5993
Contract Number Brand Code Brand Name Package Size Formulary Category Unit Price Strength Max. Reimbursable / Month Drug Contract Start Date Drug Contract End Date Restrict To Ophthalmologist Restrict To Pulmonologist Status Description Max Repeats
42 1471G CLONOTRIL 0.5MG TAB (REM) CLONAZEPA 30'S A 0.11 0.5MG 240 2026-04-01 No No 6
40 1471K APO-CLONAZEPAM 0.5MG TAB (APO/COL) 500'S A 0.04 0.5MG 240 2022-04-01 2024-03-31 6
41 1471P APO-CLONAZEPAM 0.5MG TAB (APO) 500'S A 0.035 0.5MG 240 2024-04-01 2026-03-31 6
40 14723 PMS-CLONAZEPAM 2MG TAB (PMS/COL) 100'S A 0.05 2MG 300 2022-04-01 2024-03-31 6
42 14723 PMS-CLONAZEPAM 2MG TAB (PMS) 100'S A 0.08 2MG 300 2026-04-01 No No 6
40 14726 APO-CLONAZEPAM 2MG TAB (APO/COL) 100'S A 0.06 2MG 300 2022-04-01 2024-03-31 6
40 1472B CLONOTRIL 2MG TAB (REM/SBI) CLONAZEPAM 3X10 C 0.14 2MG 0 2022-04-01 2024-03-31 0
41 1472B CLONOTRIL 2MG TAB (REM) CLONAZEPAM (C) 3X10 C 0.1414 2MG 300 2024-04-01 2026-03-31 6
42 1472B CLONOTRIL 2MG TAB (REM) CLONAZEPAM 3X10 A 0.14 2MG 300 2026-04-01 No No 6
41 1472R APO-CLONAZEPAM 2MG TAB (APO) 100'S A 0.0555 2MG 300 2024-04-01 2026-03-31 6
40 14912 MAGNESIUM SULPHATE 50% INJ (MTP/COL) 10X2ML B 1.03 50% 0 2022-04-01 2024-03-31 0
41 14912 MAGNESIUM SULPHATE 50% INJ (MTP) (B) 10X2ML B 1.5195 50% 0 2024-04-01 2026-03-31 0
42 1491AF MAGNESIUM SULPHATE 50% INJ (JLP) 50X2ML B 0.82 50% 0 2026-04-01 No No 0
42 1491AH MAGNESIUM SULPHATE 50% INJ (FSB) 10X2ML B 0.61 50% 0 2026-04-01 No No Add to Contract as Cat B 0
40 1491R MAGNESIUM SULPHATE 50% INJ (MON/PHA) 10X2ML B 0.75 50% 0 2022-04-01 2024-03-31 0
42 1491R MAGNESIUM SULPHATE 50% INJ (MON) 10X2ML B 0.83 50% 0 2026-04-01 No No 0
41 1491T MAGNESIUM SULPHATE 50% INJ (KWA) (B) 10X2ML B 1.1091 50% 0 2024-04-01 2026-03-31 0
41 1491Z LASULPHATE 50% INJ (LDP) MAGNESIUM SULPHATE (B) 10X2ML B 1.892 50% 0 2024-04-01 2026-03-31 0
40 15011 PHENOBARBITAL 15MG TAB (TEV/COL) PHENOBARBITO 28'S A 1.52 15MG 180 2022-04-01 2024-03-31 6
42 15013 PHENOBARB 15MG TAB (PMS) PHENOBARBI 500'S A 0.08 15MG 180 2026-04-01 No No 6